These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12702180)

  • 1. Adverse effects in blood donors after whole-blood donation: a study of 1000 blood donors interviewed 3 weeks after whole-blood donation.
    Newman BH; Pichette S; Pichette D; Dzaka E
    Transfusion; 2003 May; 43(5):598-603. PubMed ID: 12702180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the probability of a blood donation adverse event based on 1000 interviewed whole-blood donors.
    Newman BH; Roth AJ
    Transfusion; 2005 Nov; 45(11):1715-21. PubMed ID: 16271095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of whole-blood donor adverse events on blood donor return rates.
    Newman BH; Newman DT; Ahmad R; Roth AJ
    Transfusion; 2006 Aug; 46(8):1374-9. PubMed ID: 16934074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arm complications after manual whole blood donation and their impact.
    Newman B
    Transfus Med Rev; 2013 Jan; 27(1):44-9. PubMed ID: 22682105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of adverse events and predisposing factors in voluntary and replacement whole blood donors: A study from north India.
    Agnihotri N; Marwaha N; Sharma RR
    Asian J Transfus Sci; 2012 Jul; 6(2):155-60. PubMed ID: 22988381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return.
    Wiersum-Osselton JC; Marijt-van der Kreek T; Brand A; Veldhuizen I; van der Bom JG; de Kort W
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s28-36. PubMed ID: 23867173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood donor complications after whole-blood donation.
    Newman BH
    Curr Opin Hematol; 2004 Sep; 11(5):339-45. PubMed ID: 15666658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-blood donation: blood donor suitability and adverse events.
    Newman BH
    Curr Hematol Rep; 2004 Nov; 3(6):437-43. PubMed ID: 15496278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmavigilance-Adverse events among US Source plasma donors.
    Schreiber GB; Becker M; Fransen M; Hershman J; Lenart J; Song G; Simon T
    Transfusion; 2021 Oct; 61(10):2941-2957. PubMed ID: 34390267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of adverse reactions, subjective distress, and anxiety on retention of first-time blood donors.
    van Dongen A; Abraham C; Ruiter RA; Veldhuizen IJ
    Transfusion; 2013 Feb; 53(2):337-43. PubMed ID: 22845422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donation related fears predict vasovagal reactions and donor attrition among high school donors.
    France CR; France JL; Himawan LK; Lux P; McCullough J
    Transfusion; 2021 Jan; 61(1):102-107. PubMed ID: 32997822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the donation experience and reducing venipuncture pain by addressing fears among whole-blood and plasma donors.
    Gilchrist PT; Thijsen A; Masser BM; France CR; Davison TE
    Transfusion; 2021 Jul; 61(7):2107-2115. PubMed ID: 33904178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions: First attempt in India.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Srivastava K; Raina V
    Transfus Apher Sci; 2017 Apr; 56(2):141-146. PubMed ID: 27839968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
    Py JY; Durieux S; Barnoux M; Sapey T
    Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of immediate adverse effects associated with apheresis donation.
    McLeod BC; Price TH; Owen H; Ciavarella D; Sniecinski I; Randels MJ; Smith JW
    Transfusion; 1998 Oct; 38(10):938-43. PubMed ID: 9767744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor reactions and injuries from whole blood donation.
    Newman BH
    Transfus Med Rev; 1997 Jan; 11(1):64-75. PubMed ID: 9031492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions to blood donations: the READ project.
    Garozzo G; Crocco I; Giussani B; Martinucci A; Monacelli S; Randi V
    Blood Transfus; 2010 Jan; 8(1):49-62. PubMed ID: 20104279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applied tension may help retain donors who are ambivalent about needles.
    Ditto B; France CR; Holly C
    Vox Sang; 2010 Apr; 98(3 Pt 1):e225-30. PubMed ID: 20432513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.